Long term hormone therapy for perimenopausal and postmenopausal women (Q24201974)

2

0 references

Anne Lethaby

4

0 references

Jane Marjoribanks

1

0 references

author name string

Helen Roberts

Cochrane Database of Systematic Reviews

3

0 references

publication date

11 July 2012

0 references

published in

0 references

cites work

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

The effect of hormone replacement on physical performance in community-dwelling elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effectiveness of Alora estradiol matrix transdermal delivery system in improving lumbar bone mineral density in healthy, postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Postmenopausal hormone therapy and change in mammographic density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Baseline characteristics of the PEPI participants. Postmenopausal Estrogen/Progestin Interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effect of hormone replacement therapy on self-reported cognitive symptoms: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Remnant-like lipoproteins, hormone therapy, and angiographic and clinical outcomes: the Women's Angiographic Vitamin & Estrogen Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Women's angiographic vitamin and estrogen trial: design and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen after ischemic stroke: clinical basis and design of the Women's Estrogen for Stroke Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

A clinical trial of estrogen-replacement therapy after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen plus progestin and colorectal cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effect of estrogen therapy on gallbladder disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen plus progestin and risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

The Women's Health Initiative recruitment methods and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of estrogen plus progestin on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of combination estrogen plus progestin hormone treatment on cognition and affect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Design of the Women’s Health Initiative Clinical Trial and Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Treatment of postmenopausal osteoporosis with transdermal estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Dose effects of oral estradiol on bone mineral density in Japanese women with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized, placebo-controlled, comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Unopposed estradiol therapy in postmenopausal women: results from two randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormones and heart disease in women: the timing hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone replacement therapy, heart disease, and other considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone replacement therapy (HRT)--risks and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Association between hormone replacement therapy and subsequent stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Evidence from randomised trials on the long-term effects of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Breast cancer risk in relation to the interval between menopause and starting hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Oestrogen therapy for urinary incontinence in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone therapy in postmenopausal women and risk of endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hot flushes during the menopause transition: a longitudinal study in Australian-born women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone replacement therapy: discrepancies between evidence and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone replacement therapy to maintain cognitive function in women with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Increased risk of recurrence after hormone replacement therapy in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

The WHI estrogen-alone trial--do things look any better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hot flashes: phenomenology, quality of life, and search for treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone replacement therapy for cognitive function in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials--time out for hormone replacement therapy studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Local oestrogen for vaginal atrophy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Update in hormone therapy use in menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Menopause hormonal therapy in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Rationale, design, and conduct of the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Menopausal hormone therapy after breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

The Women’s Health Initiative Memory Study (WHIMS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Women's health initiative. Why now? What is it? What's new?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

The effects of oophorectomy and long-term mestranol therapy on the serum lipids of middle-aged women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

The ERA trial: findings and implications for the future.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Climacteric vasomotor symptoms do not imply autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

A practical guide to prescribing hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

Effects of long-term transdermal administration of estradiol on serum lipids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004143.PUB4

7 January 2021

10.1002/14651858.CD004143.PUB4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2330637

2330637

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference